$1.500
-0.085 (-5.66%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
HCAT Prediction & Forecast by Similar Chart Analysis
Alphio's HCAT stock price prediction model matches the current Health Catalyst Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.50 (-0.06%). The 1-week path is $1.54 (+2.39%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Health Catalyst Inc Stock?
Health Catalyst Inc is not a good buy right now. The current price is $1.58, which is significantly below the 52-week high of $3.36, indicating a decline of 53.0%. Additionally, the RSI is at 34.34, suggesting that the stock is oversold. The company has reported substantial losses, with a net income of -$111 million in Q1 2026 and -$40.5 million in Q2 2026, which raises concerns about its profitability. The main risk is the ongoing uncertainty around client churn and potential down-sell risks, as highlighted by analyst downgrades.
HCAT stock price ended at $1.50 on Thursday, after losing -5.66%
Health Catalyst Inc (HCAT) last closed at $1.5, losing -5.66%. These facts feed the 1-day and 1-week HCAT price prediction above.
Forecast Drivers
Health Catalyst Inc (HCAT) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches HCAT, ranked by similarity.
Seasonality analysis for HCAT
Historically the probability of a positive November return for HCAT is 0.00%. January offers the highest probability of a positive month at 57.38%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for HCAT
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $3.44 | $4.19 | $4.22 | +179.38% |
| Dec 2026 | $4.22 | $4.25 | $4.94 | +183.22% |
In 2026, Health Catalyst Inc (HCAT) is projected to range from $3.44 to $4.94.
Health Catalyst Inc 2026 monthly forecast
In Nov 2026, Health Catalyst Inc is projected to average $4.19, with a low of $3.44 and high of $4.22.
In Dec 2026, Health Catalyst Inc is projected to average $4.25, with a low of $4.22 and high of $4.94.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.